News
FDA approves BMS' Opdivo and Yervoy combination in first-lin...
Bristol-Myers Squibb’s immunotherapy combination of Opdivo and Yervoy has been approved in the US in a new indication for untreated mesothelioma, a rare but aggressive form of cancer that f
